Characterization of a cytotoxic factor in culture filtrates of Serratia marcescens

Infection and Immunity

Volumn 70, Issue 3, 2002, Pages 1121-1128

  Marty, Kent B ^a   Williams, Christopher L ^a   Guynn, Linda J ^a   Benedik, Michael J ^a   Blanke, Steven R ^a  

^a University of Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; CATION; CYTOTOXIC FACTOR; EDETIC ACID; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; PROTEINASE;

ARTICLE; BACTERIAL MUTATION; BACTERIUM CULTURE; BIOCHEMISTRY; CATION TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; ENZYME RELEASE; GENETIC ANALYSIS; HEAT TREATMENT; HELA CELL; HUMAN; HUMAN CELL; INCUBATION TIME; MAMMAL CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SERRATIA MARCESCENS; STRAIN DIFFERENCE; STRAIN IDENTIFICATION;

BACTERIAL TOXINS; CYTOTOXINS; ESCHERICHIA COLI; HELA CELLS; HUMANS; METALLOENDOPEPTIDASES; RECOMBINANT PROTEINS; SERRATIA MARCESCENS; ZINC;

EID: 0036181917     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.3.1121-1128.2002     Document Type: Article

References (67)

1. Serratia marcescens infections
2. Colonization and infection by Serratia species in a paediatric surgical intensive care unit
3. Serratia marcescens outbreak associated with extrinsic contamination of 1% chlorxylenol soap
4. Serratia marcescens keratoconjunctivitis
5. Antibiotic resistance and putative virulence factors of Serratia marcescens with respect to O and K serotypes
6. Evidence of an efflux pump in Serratia marcescens
7. Epidemiological markers of Serratia marcescens isolates causing nosocomial infections in Spain (1981-1991)
8. Serratia marcescens nosocomial outbreak due to contamination of hexetidine solution
9. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines
10. Sensitive mutants of bacteriophage λ
11. Detection of cytotoxic activity on Vero cells in clinical isolates of Serratia marcescens
12. Culture conditions affect cytotoxin production by Serratia marcescens
13. Outbreak of chest infections with Serratia marcescens
14. Heterogeneous Serratia marcescens genotypes from a nosocomial pediatric outbreak
15. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture
16. Containment of a multiresistant Serratia marcescens outbreak
17. Contamination of central venous catheters. The skin insertion wound is a major source of contamination
18. Episomic transfer between Salmonella typhosa and Serratia marcescens
19. Isolation and physico-chemical properties of homogenous nuclease from Serratia marcescens
20. Common themes in microbial pathogenicity revisited
21. Comparison of [3H]thymidine incorporation with MTT- and MTS-based bioassays for human and murine IL-2 and IL-4 analysis. Tetrazolium assays provide markedly enhanced sensitivity
22. Microculture tetrazolium assays: A comparison between two new tetrazolium salts, XTT and MTS
23. An epidemiological study of Serratia marcescens isolates from nosocomial infections by enzyme electrophoresis
24. Nosocomial infection in the community hospital: Severe infection due to Serratia species
25. Effect of prednisolone on renal scarring in rats following infection with Serratia marcescens
26. Bacterial extracellular zinc-containing metalloproteases
27. Serratia marcescens
28. Genetic analysis of extracellular proteins of Serratia marcescens
29. Serratia marcescens keratitis: Strain-specific corneal pathogenesis in rabbits
30. Adhesion and growth of Serratia marcescens on artificial closed eye tears soaked hydrogel contact lenses
31. An examination of the clonal variants of Serratia marcescens that infect the eye during contact lens wear
32. Bacterial contamination of the pressure receiver of a vitrectomy machine
33. The serratial 56K protease as a major pathogenic factor in serratial keratitis. Clinical and experimental study
34. Long-lasting contamination of a vitrectomy apparatus with Serratia marcescens
35. Repeated epidemics caused by extended-spectrum beta-lactamase-producing Serratia marcescens strains
36. Characterization of rabbit corneal damage produced by Serratia keratitis and by a Serratia protease
37. Role of microbial proteases in pathogenesis
38. Pathogenic potentials of bacterial proteases
39. 2-macroglobulin, and regeneration of protease activity and cytotoxicity
40. Pathogenic mechanisms induced by microbial proteases in microbial infections
41. Clinical and microbiological survey of Serratia marcescens infection during HIV disease
42. The cell-bound hemolysin of Serratia marcescens contributes to uropathogenicity
43. A generalized transducing phage of Serratia marcescens
44. Purification and characterization of four proteases from clinical isolate of Serratia marcescens kums 3958
45. Pathogenesis of serratial infection: Activation of the Hageman factor-prekallikrein cascade by serratial protease
46. Molecular mechanisms of action of bacterial protein toxins
47. Serratia marcescens lung abscess in a child with autoimmune neutropenia
48. Degradation of protease inhibitors, immunoglobulins, and other serum proteins by Serratia protease and its toxicity to fibroblast in culture
49. Bacterial protein toxins penetrate cells via a four-step mechanism
50. The mechanism of action of tetanus and botulinum neurotoxins
51. Botulinum neurotoxins: Mechanism of action and therapeutic applications
52. Epidemic septic arthritis caused by Serratia marcescens and associated with a benzalkanium chloride antiseptic
53. Survival of Serratia marcescens in benzalkonium chloride and in multiple-dose medication vials: Relationship to epidemic septic arthritis
54. Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs: Analysis of the intracellular consequences in macrophages
55. Tetanus and botulinum neurotoxins: Mechanism of action and therapeutic uses
56. Evolution of pathogen virulence: The role of variation in host phenotype
57. Bacterial epithelial cell cross talk
58. Aortic valve or root replacement with cryopreserved homograft for active infectious endocarditis
59. Gram-negative bacteremia in open-heart-surgery patients traced to probable tap-water contamination of pressure-monitoring equipment
60. Interaction of bladder glycoprotein GP51 with uropathogenic bacteria
61. Production of active Serratia marcescens metalloprotease from Escherichia coli by alpha-hemolysin HlyB and HlyD
62. Serratia marcescens infections in neonatal departments: Description of an outbreak and review of the literature
63. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages
64. Bacteremia due to Serratia marcescens
65. Differences in the pathogenesis of bacteria isolated from contact-lens-induced infiltrative conditions
66. Mutants of Serratia marcescens defective or superactive in the release of a nuclease
67. Serratia marcescens bacteremia: Clinical features and antimicrobial susceptibilities of the isolates